Patents by Inventor Fahad Al-Obeidi

Fahad Al-Obeidi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020022596
    Abstract: The present invention relates to new malonic acid derivatives of the formula 1, 1
    Type: Application
    Filed: February 23, 2001
    Publication date: February 21, 2002
    Inventors: Fahad A. Al-Obeidi, Armin Walser, Peter Wildgoose
  • Patent number: 6337344
    Abstract: The present invention relates to the inhibition of blood clotting proteins, and more particularly, to indole derivatives of formula (I), in which R1a, R1b, R1c R1d, R2, R3, R4 and A are defined as indicated in the claims. The compounds of formula (I) are inhibitors of the blood clotting enzyme factor Xa. The invention also relates to processes for the preparation of the compounds of formula (I), to methods of inhibiting factor Xa activity and of inhibiting blood clotting, to use of the compounds of formula (I) in the treatment and prophylaxis of diseases which can be cured or prevented by the inhibition of factor Xa activity such as thromboembolic diseases, and to the use of the compounds of formula (I) in the preparation of medicaments to be applied in such diseases.
    Type: Grant
    Filed: August 14, 2000
    Date of Patent: January 8, 2002
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Elisabeth Defossa, Uwe Heinelt, Otmar Klingler, Gerhard Zoller, Fahad A. Al-Obeidi, Armin Walser, Peter Wildgoose, Hans Matter
  • Patent number: 6177405
    Abstract: The useful cyclic peptides cyclo[Thr-Lys-Pro-Arg-Gly] and cyclo[Thr-Lys-Pro-Arg-Asp] are disclosed.
    Type: Grant
    Filed: July 22, 1992
    Date of Patent: January 23, 2001
    Inventors: Kenji Nishioka, John S. McMurray, B. Montgomery Pettitt, Fahad Al-Obeidi
  • Patent number: 5849510
    Abstract: The invention provides compounds which specifically inhibit factor Xa activity. The compounds consist of the structure X.sub.1 -YIR-X.sub.2, wherein X.sub.1 is H, acyl, alkyl, acylalkyl, arylalkyl or one or more amino acids, and X.sub.2 is a modified C-terminal group, one or more carboxy-protecting groups or one or more amino acids or other substituent, and Y, I and R are tyrosine, isoleucine and arginine, respectively, or peptidomimetic or organic structures that possess the same functional activity as Y, I and R, respectively. In addition, the present invention provides a compound having the structure A1-A2-(A3).sub.m --B, where m is 0 or 1. A compound of the invention can be linear or cyclic and can be about 2 and 43 residues in length. A compound of the invention is characterized, in part, in that it exhibits a specific inhibition of factor Xa activity with a K.sub.i of .ltoreq.100 .mu.M, preferably .ltoreq.
    Type: Grant
    Filed: October 8, 1997
    Date of Patent: December 15, 1998
    Assignee: Selectide Corporation
    Inventors: Fahad Al-Obeidi, Michal Lebl, James A. Ostrem, Pavel Safar, Alena Stierandova, Peter Strop, Armin Walser
  • Patent number: 5714576
    Abstract: Linear and Cyclic Alpha-MSH fragment analogues of Ac-Nle.sup.4 -Glu.sup.5 -His.sup.6 -D-Phe.sup.7 -Arg.sup.8 -Try.sup.9 -Gly.sup.10 -NH.sub.2. The method of stimulating melanocytes by the transdermal application of these biologically-active analogues and compositions comprising these analogues for use in the method are disclosed.
    Type: Grant
    Filed: April 7, 1997
    Date of Patent: February 3, 1998
    Assignee: Competitive Technologies, Inc.
    Inventors: Victor J. Hruby, Mac E. Hadley, Fahad Al-Obeidi
  • Patent number: 5674839
    Abstract: Cyclic Alpha-MSH fragment analogues of Ac-Nle.sup.4 -Glu.sup.5 -His.sup.6 -D-Phe.sup.7 -Arg.sup.8 -Try.sup.9 -Gly.sup.10 -NH.sub.2. The method of stimulating melanocytes by the transdermal application of these biologically-active analogues and compositions comprising these analogues for use in the method are disclosed.
    Type: Grant
    Filed: December 6, 1994
    Date of Patent: October 7, 1997
    Assignee: Competitive Technologies, Inc.
    Inventors: Victor J. Hruby, Mac E. Hadley, Fahad Al-Obeidi